| scholarly article | Q13442814 |
| P2093 | author name string | Sajin Maria | |
| Costache Mariana | |||
| Dumitru Adrian Vasile | |||
| Lazaroiu Anca Mihaela | |||
| Mehotin Corina Nicoleta | |||
| Patrascu Oana Maria | |||
| P2860 | cites work | Nuclear ING2 expression is reduced in human cutaneous melanomas | Q24652926 |
| MITF: master regulator of melanocyte development and melanoma oncogene | Q28256859 | ||
| Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions | Q33343565 | ||
| Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article | Q34183543 | ||
| Novel multiple markers to distinguish melanoma from dysplastic nevi | Q34427923 | ||
| Molecular aspects of melanocytic dysplastic nevi | Q34622005 | ||
| Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues | Q36109510 | ||
| The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management | Q36752192 | ||
| The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects | Q36762792 | ||
| Dysplastic nevus--a risk factor of developing skin melanoma clinical and epidemiological study with retrospective review of literature | Q37905745 | ||
| HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups | Q41170059 | ||
| Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma. | Q41901851 | ||
| The role of Bcl-2 family members in the progression of cutaneous melanoma | Q47404782 | ||
| Expression of cell cycle and apoptosis regulatory proteins and telomerase in melanocitic lesions. | Q53556418 | ||
| HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma | Q69086099 | ||
| Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma | Q73592548 | ||
| Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma | Q80034682 | ||
| Myeloid leukemia-1 expression in benign and malignant melanocytic lesions | Q80927723 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 38-43 | |
| P577 | publication date | 2016-03-01 | |
| P1433 | published in | Mædica | Q26841884 |
| P1476 | title | Expression of Bcl-2, Melan A and HMB-45 in Dysplastic Nevi | |
| P478 | volume | 11 |
Search more.